8-K
filed February 13, 2026, 6:59 PM ET
ticker CTXR
CIK 0001506251
earnings
confidence high
sentiment neutral
materiality 0.65
Citius Pharma posts first revenue of $3.9M from LYMPHIR launch; Nasdaq warns of bid price deficiency
Citius Pharmaceuticals, Inc.
2026-Q1 EPS reported
-$0.38
revenue$3,944,111
- Q1 FY2026 revenue $3.9M from initial LYMPHIR sales; net loss $8.2M ($0.41 loss per share).
- Cash and equivalents $7.7M; raised ~$20.9M from equity financings in quarter.
- Nasdaq notified company of bid price deficiency; has until Aug 10, 2026 to regain compliance.
- LYMPHIR launched Dec 2025; early physician adoption; international patient access via Named Patient Programs.
- Late-stage pipeline includes Mino-Lok and Halo-Lido; engaging with FDA on next steps.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-015895
- form_type
- 8-K
- ticker
- CTXR
- cik
- 0001506251
- company_name
- Citius Pharmaceuticals, Inc.
- filed_at
- 2026-02-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:35.257746+00:00
- generated_at
- 2026-05-16T02:46:06.935060+00:00
- sec_items
- ["2.02", "3.01", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-015895
- json_url
- https://secwatch.observer/filing/0001213900-26-015895.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-015895.md
- text_url
- https://secwatch.observer/filing/0001213900-26-015895.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1506251/000121390026015895/0001213900-26-015895-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1506251/000121390026015895/ea0276948-8k_citius.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
RANI
Rani Therapeutics Q1 net loss narrows to $8M; Nasdaq bid price non-compliance; CFO to depart
Rani Therapeutics Holdings, Inc.
May 15, 2026, 4:08 PM ET
earnings
Items 2.02, 3.01, 5.02, 9.01
same fact type: exchange_compliance_notice
same SEC item: 2.02, 3.01, 9.01
same event type: earnings
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 11, 2026, the Company received a letter from the Nasdaq Stock Exchange LLC (“Nasdaq”), notifying the Company that, based on the closing bid price of the Company’s Class A common stock, par value $0.0001 per share (th
Filing page
SEC filing
GENC
Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing
GENCOR INDUSTRIES INC
June 1, 2026, 4:09 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY
Filing page
SEC filing
ATNM
Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26
Actinium Pharmaceuticals, Inc.
May 29, 2026, 5:10 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 27, 2026, Actinium Pharmaceuticals, Inc.
(the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating
that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company
Guide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more
if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31,
2026, the Company reported stockholders’ equity of approximately
Filing page
SEC filing
CSAI
Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing
CLOUDASTRUCTURE, INC.
May 29, 2026, 5:09 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 26, 2026, Cloudastructure,
Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq
Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for
the period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which
requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional
time to review and confirm the accounting treatment for its outstand
Filing page
SEC filing
GURE
Gulf Resources receives Nasdaq delisting notice for late Q1 2026 10-Q filing
GULF RESOURCES, INC.
May 29, 2026, 4:45 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 26, 2026, Gulf Resources
(the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq
Stock Market LLC (“Nasdaq”), indicating that, as a result of not having timely filed its quarterly report on Form 10-Q for
the quarter ended March 31, 2026 (the “Form 10-Q”), and the Company remains delinquent in filing its annual report on Form
10-K for the year ended December 31, 2025 (the “Initial Delinquent Filing”), the Company is in non-compliance with Nasdaq
Listing Rule 5250(c)(1), which requires timely filing all required periodic financial reports wit
Filing page
SEC filing
FTHM
Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan
Fathom Holdings Inc.
May 29, 2026, 4:15 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter
Filing page
SEC filing
RR
Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing
RICHTECH ROBOTICS INC.
May 28, 2026, 4:49 PM ET
regulatory
Items 3.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 22, 2026, Richtech
Robotics Inc., a Nevada corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing
Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company is not in compliance
with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), because it has not timely filed its Quarterly Report on Form 10-Q
for the period ended March 31, 2026 (the “ Form 10-Q ”) with the U.S. Securities and Exchange Commission (the “ SEC ”). The
Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Com
Filing page
SEC filing
CDT
CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan
CDT Equity Inc.
May 28, 2026, 4:30 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
February 9, 2026, Nasdaq
Stock Market LLC (“Nasdaq”) notified the Company that for the last 30 consecutive business days, the bid price for the Company’s
common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to
Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq
Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with
the Bid Price Rule. If at any time before August 10, 2026, the bid price of the Company's co
Comparable filing
May 21, 2026, CDT Equity Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Listing
Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with
Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”) because the Company did not file its Quarterly Report
on Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”) in a timely manner, as required for continued
listing on The Nasdaq Capital Market. The Notice has no immediate effect on the listing or trading of the Company’s
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.